An influx of COVID-19 related hospitalizations brings patients presenting a spectra of symptoms, requiring a spectra of treatments
– this convergence could lead to an increased risk of C. difficile.
If prioritized COVID-19 testing has you making tough decisions about your C. difficile testing standard and algorithm – it shouldn't!
Easy, flexible workflow – integrated seamlessly for a single specimen or high-throughput batching up to 12 tests at a time.
Minimal training – get up and running quickly
The Power of Virena – enhanced diagnostics featuring data analytics and surveillance
Compact footprint – measuring 9.4"x 9.4"x 5.9" deployable practically anywhere
To learn how our Solana C. difficile Assay combined with the data-rich analytical tools of Virena can help you sustain your molecular testing algorithm, call
Quidel Inside Sales at 858.431.5814,
or fill out the form below:
Maintain your molecular testing standard for
C. difficile with Solana.
The Accurate. Sustainable.
Molecular C. difficile Solution.